UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 235

Sortiert nach

Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making

Pharmacoepidemiology and drug safety, 2017-09, Vol.26 (9), p.1033-1039

2017

Volltextzugriff (PDF)

Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

Value in health, 2017-09, Vol.20 (8), p.1003-1008

2017

Volltextzugriff (PDF)

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

Journal of managed care & specialty pharmacy, 2023-07, Vol.29 (7), p.807

2023

Volltextzugriff (PDF)

The Rise of Prescription Digital Therapeutics in Behavioral Health

Advances in therapy, 2022-12, Vol.39 (12), p.5301-5306

2022

Volltextzugriff (PDF)

Predicting Optimal Hypertension Treatment Pathways Using Recurrent Neural Networks

International journal of medical informatics (Shannon, Ireland), 2020-07, Vol.139, p.104122-104122, Article 104122

2020

Volltextzugriff (PDF)

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Cancer epidemiology, biomarkers & prevention, 2021-06, Vol.30 (6), p.1106-1113

2021

Volltextzugriff (PDF)

Cancer incidence in immunocompromised patients: a single-center cohort study

BMC cancer, 2023-01, Vol.23 (1), p.33-33, Article 33

2023

Volltextzugriff (PDF)

Tumor mutational burden in lung cancer: a systematic literature review

Oncotarget, 2019-11, Vol.10 (61), p.6604-6622

2019

Volltextzugriff (PDF)

Impact of a genetic counseling requirement prior to genetic testing

BMC health services research, 2018-03, Vol.18 (1), p.165-165, Article 165

2018

Volltextzugriff (PDF)

Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients

Journal of managed care & specialty pharmacy, 2018-12, Vol.24 (12), p.1250

2018

Volltextzugriff (PDF)

Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review

BMC health services research, 2019-10, Vol.19 (1), p.737-737, Article 737

2019

Volltextzugriff (PDF)

Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods

Journal of comparative effectiveness research, 2024-05, Vol.13 (5), p.e230041-e230041

2024

Volltextzugriff (PDF)

The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs

Personalized medicine, 2018-07, Vol.15 (4), p.291-301

2018

Volltextzugriff (PDF)

Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome

Pediatric blood & cancer, 2019-05, Vol.66 (5), p.e27629-n/a

2019

Volltextzugriff (PDF)

Pharmacy Expenditures for Children With Serious Chronic Illness

JAMA : the journal of the American Medical Association, 2016-02, Vol.315 (7), p.706

2016

Volltextzugriff (PDF)

Physician Adherence to ACR Gout Treatment Guidelines: Perception Versus Practice

Postgraduate medicine, 2014-05, Vol.126 (3), p.257-267

2014

Volltextzugriff (PDF)

BRCA testing and outcomes in women with breast cancer

Breast cancer research and treatment, 2021-04, Vol.186 (3), p.839-850

2021

Volltextzugriff (PDF)

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer

BMC health services research, 2021-01, Vol.21 (1), p.58-58, Article 58

2021

Volltextzugriff (PDF)

Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2019-07, Vol.21 (7), p.1725-1733

2019

Volltextzugriff (PDF)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia

BMC health services research, 2018-12, Vol.18 (1), p.1003-1003, Article 1003

2018

Volltextzugriff (PDF)

Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting

Clinical therapeutics, 2009-05, Vol.31 (5), p.1116-1123

2009

Volltextzugriff (PDF)

Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis

Pulmonary medicine, 2023-01, Vol.2023, p.5082499-7

2023

Volltextzugriff (PDF)

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Journal of comparative effectiveness research, 2015-09, Vol.4 (5), p.485-504

2015

Volltextzugriff (PDF)

Toward a Consensus on the QALY

Value in health, 2009-03, Vol.12 (s1), p.S31-S35

2009

Volltextzugriff (PDF)

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data

Journal of managed care & specialty pharmacy, 2014-07, Vol.20 (7), p.691-700

2014

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(235)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making

Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

The Rise of Prescription Digital Therapeutics in Behavioral Health

Predicting Optimal Hypertension Treatment Pathways Using Recurrent Neural Networks

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Cancer incidence in immunocompromised patients: a single-center cohort study

Tumor mutational burden in lung cancer: a systematic literature review

Impact of a genetic counseling requirement prior to genetic testing

Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients

Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review

Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods

The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs

Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome

Pharmacy Expenditures for Children With Serious Chronic Illness

Physician Adherence to ACR Gout Treatment Guidelines: Perception Versus Practice

BRCA testing and outcomes in women with breast cancer

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer

Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia

Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting

Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Toward a Consensus on the QALY

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data

Suchergebnisse filtern